Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Once-daily oxybutynin assessed in urinary urge incontinence

Dec. 27, 1999

Vivus seeks FDA approval for new impotence drug

Dec. 23, 1999

Vasomax progress updated by Zonagen

Dec. 22, 1999

NexMed initiates phase II trials of alprostadil cream in U.S.

Dec. 22, 1999

Milestone for Gene Logic in kidney disease collaboration

Dec. 21, 1999

Herbomineral preparation shows efficacy in animal model of BPH

Dec. 15, 1999

SS-cream increases ejaculatory latency and satisfaction in patients with premature ejaculation

Dec. 14, 1999

Quark Biotech, Taisho investigate new treatments for renal disease

Dec. 14, 1999

New series of uroselective alpha1-adrenoceptor antagonists in development at Abbott

Dec. 7, 1999

Interneuron licenses U.S. rights to urinary incontinence treatment

Nov. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.